JOHN W. CHILDS - 03 Feb 2026 Form 3 Insider Report for Veradermics, Inc (MANE)

Role
Director
Signature
/s/ Michael Greco, Attorney-in-Fact
Issuer symbol
MANE
Transactions as of
03 Feb 2026
Net transactions value
$0
Form type
3
Filing time
03 Feb 2026, 21:05:49 UTC
Previous filing
17 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
CHILDS JOHN W Director C/O VERADERMICS, INCORPORATED, 470 JAMES ST., NEW HAVEN /s/ Michael Greco, Attorney-in-Fact 03 Feb 2026 0001027035

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MANE Series A Convertible Preferred Stock 03 Feb 2026 Common Stock 480,269 See Footnote F1, F2
holding MANE Series B Convertible Preferred Stock 03 Feb 2026 Common Stock 906,862 See Footnote F2, F3
holding MANE Series C Convertible Preferred Stock 03 Feb 2026 Common Stock 520,758 See Footnote F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A Convertible Preferred Stock is convertible into shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), on a 10.067-for-1 basis and has no expiration date. The Series A Convertible Preferred Stock will automatically convert into Common Stock immediately prior to the closing of the Issuer's initial public offering.
F2 Shares held by J.W. Childs Associates (FL), L.P. John W. Childs 2013 Revocable Trust is the sole owner of J.W. Childs Associates (FL), L.P. The Reporting Person, a member of the board of directors of the Issuer, is Trustee of John W. Childs 2013 Revocable Trust and may be deemed to hold voting and dispositive power with respect to these securities.
F3 Each share of Series B Convertible Preferred Stock is convertible into shares of the Issuer's Common Stock on a 10.067-for-1 basis and has no expiration date. The Series B Convertible Preferred Stock will automatically convert into Common Stock immediately prior to the closing of the Issuer's initial public offering.
F4 Each share of Series C Convertible Preferred Stock is convertible into shares of the Issuer's Common Stock on a 10.067-for-1 basis and has no expiration date. The Series C Convertible Preferred Stock will automatically convert into Common Stock immediately prior to the closing of the Issuer's initial public offering.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney